ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

No reported Net Receivables figures are available to summarize.

Net Receivables history

Currency unavailable · from the balance sheet

No Net Receivables data reported for this period type.

Net Receivables vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Net Receivables for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SLNSilence Therapeutics plcMar 2026$22.22M USD+31.9%+199.6%19.3%
MGTXMeiraGTx Holdings plcMar 2026$17.96M USD+243.7%-14.3%7.3%
RNAAtrium Therapeutics, Inc.Mar 2026$15M USD——5.1%
STOKStoke Therapeutics, Inc.Mar 2026$6.14M USD+913.4%+137.8%1.4%
PRQRProQR Therapeutics N.V.Mar 2026€2.72M EUR-8.7%-55.1%2.7%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$1.34M USD-90.8%+26.3%0.5%
BNTCBenitec Biopharma Inc.Mar 2026$3K USD+0.0%+122.4%0.0%
PRMEPrime Medicine, Inc.Mar 2026$0 USD-100.0%—0.0%
WVEWave Life Sciences Ltd.Mar 2026$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+0.0%+74.3%1.4%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.